相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dysregulation of mprF and dltABCD expression among daptomycin-non-susceptible MRSA clinical isolates
Arnold S. Bayer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system
David R. Cameron et al.
SCIENTIFIC REPORTS (2016)
Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides
Arnold S. Bayer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Impact of daptomycin resistance on Staphylococcus aureus virulence
David R. Cameron et al.
VIRULENCE (2015)
Heterogeneity of mprF Sequences in Methicillin-Resistant Staphylococcus aureus Clinical Isolates: Role in Cross-Resistance between Daptomycin and Host Defense Antimicrobial Peptides
Arnold S. Bayer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
Multi-drug-resistant Staphylococcus aureus and future chemotherapy
K. Hiramatsu et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Deciphering the Metabolism of Undecaprenyl-Phosphate: The Bacterial Cell-Wall Unit Carrier at the Membrane Frontier
Guillaume Manat et al.
MICROBIAL DRUG RESISTANCE (2014)
Phenotypic and Genotypic Characterization of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Strains: Relative Roles of mprF and dlt Operons
Nagendra N. Mishra et al.
PLOS ONE (2014)
Vancomycin-intermediate resistance in Staphylococcus aureus
Keiichi Hiramatsu et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2014)
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall
Arnold S. Bayer et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
Brian J. Werth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Correlation of Cell Membrane Lipid Profiles with Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus
Nagendra N. Mishra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Helga Thorvaldsdottir et al.
BRIEFINGS IN BIOINFORMATICS (2013)
Whole-Genome Sequencing Reveals a Link Between β-Lactam Resistance and Synthetases of the Alarmone (p)ppGpp in Staphylococcus aureus
Michael M. Mwangi et al.
MICROBIAL DRUG RESISTANCE (2013)
Additional Routes to Staphylococcus aureus Daptomycin Resistance as Revealed by Comparative Genome Sequencing, Transcriptional Profiling, and Phenotypic Studies
Yang Song et al.
PLOS ONE (2013)
Increased Cell Wall Teichoic Acid Production and D-alanylation Are Common Phenotypes among Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus (MRSA) Clinical Isolates
Ute Bertsche et al.
PLOS ONE (2013)
VraSR Two-Component Regulatory System Contributes to mprF-Mediated Decreased Susceptibility to Daptomycin in In Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus
Shrenik Mehta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics
Andrew D. Berti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Anton Bankevich et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2012)
Serine/Threonine Phosphatase Stp1 Contributes to Reduced Susceptibility to Vancomycin and Virulence in Staphylococcus aureus
David R. Cameron et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Reduced Susceptibility to Host-Defense Cationic Peptides and Daptomycin Coemerge in Methicillin-Resistant Staphylococcus aureus From Daptomycin-Naive Bacteremic Patients
Nagendra N. Mishra et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus
Anton Y. Peleg et al.
PLOS ONE (2012)
Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical Methicillin-Resistant Staphylococcus aureus Isolates Obtained before and after Daptomycin Treatment Failure
Susan Boyle-Vavra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureus
Mitsutaka Shoji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Use of Antistaphylococcal β-Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
Abhay Dhand et al.
CLINICAL INFECTIOUS DISEASES (2011)
Characterization of Staphylococcus aureus Cardiolipin Synthases 1 and 2 and Their Contribution to Accumulation of Cardiolipin in Stationary Phase and within Phagocytes
T. Koprivnjak et al.
JOURNAL OF BACTERIOLOGY (2011)
Lysine Nζ-Decarboxylation Switch and Activation of the β-Lactam Sensor Domain of BlaR1 Protein of Methicillin-resistant Staphylococcus aureus
Oleg Borbulevych et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
Benjamin P. Howden et al.
PLOS PATHOGENS (2011)
Activities of High-Dose Daptomycin, Vancomycin, and Moxifloxacin Alone or in Combination with Clarithromycin or Rifampin in a Novel In Vitro Model of Staphylococcus aureus Biofilm
Jorge Parra-Ruiz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms
Soo-Jin Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD
Barry I. Eisenstein et al.
CLINICAL INFECTIOUS DISEASES (2010)
Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections
Friederike Traunmueller et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains
Soo-Jin Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus
Nagendra N. Mishra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Enhanced Expression of dltABCD Is Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate of Staphylococcus aureus
Soo-Jin Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Evidence for a dual role of PBP1 in the cell division and cell separation of Staphylococcus aureus
Sandro F. F. Pereira et al.
MOLECULAR MICROBIOLOGY (2009)
Waves of resistance: Staphylococcus aureus in the antibiotic era
Henry F. Chambers et al.
NATURE REVIEWS MICROBIOLOGY (2009)
The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
Christoph M. Ernst et al.
PLOS PATHOGENS (2009)
Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus
Francesc Marco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The use of daptomycin for Staphylococcus aureus infections in critical care medicine
Jeffrey Alder
CRITICAL CARE CLINICS (2008)
Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate
Madhukiran H. Murthy et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway
Sarah Dubrac et al.
MOLECULAR MICROBIOLOGY (2008)
Beyond MRSA: The growing menace of hVISA and VISA
Deepti Bulchandani et al.
SOUTHERN MEDICAL JOURNAL (2008)
Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding
Tiffanny Jones et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus
Sarah Dubrac et al.
JOURNAL OF BACTERIOLOGY (2007)
Identification of a soluble diacylglycerol kinase required for lipoteichoic acid production in Bacillus subtilis
Agoston Jerga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing
Michael M. Mwangi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanisms of daptomycin resistance in Staphylococcus aureus
Glenn W. Kaatz et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus
L Friedman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin
DJ Skiest
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
YycH regulates the activity of the essential YycFG two-component system in Bacillus subtilis
H Szurmant et al.
JOURNAL OF BACTERIOLOGY (2005)
Cell-surface alterations in class IIa bacteriocin-resistant Listeria monocytogenes strains
V Vadyvaloo et al.
MICROBIOLOGY-SGM (2004)
Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus
M Kuroda et al.
MOLECULAR MICROBIOLOGY (2003)
Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo:: Multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S-aureus under the impact of antibiotics administered for chemotherapy
K Sieradzki et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity
AS Bayer et al.
INFECTION AND IMMUNITY (2000)
分享论文
